This is a preview of subscription content, log in via an institution to check access.
References
Pisinger C, Wennike P, Tønnesen P. Nicotine replacement therapy in patients with coronary heart disease. Recommendations for effective use. CNS Drugs 1999; 12(2): 99–110
Fiore MC, Bailey WC, Cohen SJ, et al. Smoking cessation. Clinical practice guideline No 18, AHCPR 96-0692. Rockville: U.S. Department of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research, 1996
Silagy C, Mant D, Fowler G, et al. Meta-analysis on efficacy of nicotine replacement therapies in smoking cessation. Lancet 1994; 343: 139–42
Joseph AM, Norman SM, Ferry LH, et al. The safety of transdermal nicotine as an aid to smoking cessation in patients with cardiac disease. N Engl J Med 1996; 335: 1792–8
Working Group for the Study of Transdermal Nicotine in Patients with Coronary Artery Disease. Nicotine replacement therapy for patients with coronary artery disease. Arch Intern Med 1994; 154: 989–95
U.S. Food and Drug Administration. Transcript of the 23rd Meeting of the U.S. Food and Drug Administration. U.S. Food and Drug Administration, 1992
McNabb ME, Ebert RV, McCusker K. Plasma nicotine levels produced by chewing nicotine gum. JAMA 1982; 248: 865–8
Rights and permissions
About this article
Cite this article
Don’t forget nicotine replacement therapy in smokers with cardiovascular disease. Drugs Ther. Perspect 16, 4–6 (2000). https://doi.org/10.2165/00042310-200016040-00002
Published:
Issue Date:
DOI: https://doi.org/10.2165/00042310-200016040-00002